search
Back to results

The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis

Primary Purpose

Radiation Proctitis, Probiotics, Glutamine

Status
Recruiting
Phase
Phase 2
Locations
China
Study Type
Interventional
Intervention
Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules
Sponsored by
West China Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Radiation Proctitis

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • locally advanced rectal adenocarcinoma diagnosed by histopathology; clinical stage T3/4 or N+(AJCC,8th), no metastasis; and planned to receive preoperative neoadjuvant concurrent chemoradiotherapy.
  • without other malignant tumors;
  • Those without serious heart, liver, kidney and other diseases;
  • ECOG score: 0-1.

Exclusion Criteria:

  • Complicated with ulcerative colitis or Crohn's disease;
  • Complicated with severe organ insufficiency, severe diabetes, and heart disease;
  • Pregnant and lactating women;
  • Abnormal bowel movements with systemic and metabolic diseases;
  • The patient has a history of using systemic antibiotics and intestinal active bacteria in the past 1 month.

Sites / Locations

  • West China HospitalRecruiting
  • Xin WangRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

combination therapy group

control group

Arm Description

From the first day of chemoradiotherapy, live combined Bifidobacterium and Lactobacillus tablets(2000mg each time, 3 times/day) combined with compound glutamine enteric-coated capsules (3 capsules each time, 3 times/day) until 1 month after the end of chemoradiotherapy.

After the start of chemoradiotherapy, the control group don't take the experimental drug orally . When patients have radiation proctitis of grade ≥2, they would be crossed over to the combined treatment group:live combined Bifidobacterium and Lactobacillus tablets(2000mg each time, 3 times/day) combined with compound glutamine enteric-coated capsules (3 capsules each time, 3 times/day) until 1 month after the end of chemoradiotherapy.

Outcomes

Primary Outcome Measures

Incidence of radiation proctitis
Incidence of grade ≥2 radiation proctitis in combination therapy group

Secondary Outcome Measures

remission rate of radiation proctitis
remission rate of radiation proctitis after combined treatment in control group developed radiation proctitis of grade ≥2

Full Information

First Posted
May 6, 2022
Last Updated
July 12, 2022
Sponsor
West China Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05406882
Brief Title
The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis
Official Title
The Effects of Bifidobacterium and Lactobacillus Tablets Combined With Compound Glutamine in the Prevention and Treatment of Radiation Proctitis.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 15, 2022 (Actual)
Primary Completion Date
April 15, 2024 (Anticipated)
Study Completion Date
September 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
West China Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Radiation proctitis is a common complication after radiation therapy for pelvic tumors. The investigators found that live bifidobacterium and lactobacillus tablets combined with compound glutamine enteric-coated capsules can significantly relieve the symptoms of radiation proctitis through preliminary clinical practice, but the mechanism is unknown. Through a prospective randomized controlled study, this study intends to investigate the incidence of grade 2 or higher acute radiation proctitis in patients of locally advanced rectal cancer after radiotherapy with the combined therapy. And through various scales, next-generation sequencing methods and other methods to evaluate the clinical symptoms, colonoscopy, imaging, and changes in the species and abundance of intestinal flora before and after treatment. To further explore the related pathways and mechanisms affecting radiation proctitis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Radiation Proctitis, Probiotics, Glutamine, Gut Microbiota, Bifidobacterium

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2, Phase 3
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
176 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
combination therapy group
Arm Type
Experimental
Arm Description
From the first day of chemoradiotherapy, live combined Bifidobacterium and Lactobacillus tablets(2000mg each time, 3 times/day) combined with compound glutamine enteric-coated capsules (3 capsules each time, 3 times/day) until 1 month after the end of chemoradiotherapy.
Arm Title
control group
Arm Type
No Intervention
Arm Description
After the start of chemoradiotherapy, the control group don't take the experimental drug orally . When patients have radiation proctitis of grade ≥2, they would be crossed over to the combined treatment group:live combined Bifidobacterium and Lactobacillus tablets(2000mg each time, 3 times/day) combined with compound glutamine enteric-coated capsules (3 capsules each time, 3 times/day) until 1 month after the end of chemoradiotherapy.
Intervention Type
Drug
Intervention Name(s)
Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules
Other Intervention Name(s)
Probiotics、Glutamine
Intervention Description
Live Combined Bifidobacterium and Lactobacillus Tablets:probiotics. Compound Glutamine Entersoluble capsules:combined traditional Chinese medicine and glutamine
Primary Outcome Measure Information:
Title
Incidence of radiation proctitis
Description
Incidence of grade ≥2 radiation proctitis in combination therapy group
Time Frame
two months
Secondary Outcome Measure Information:
Title
remission rate of radiation proctitis
Description
remission rate of radiation proctitis after combined treatment in control group developed radiation proctitis of grade ≥2
Time Frame
two months
Other Pre-specified Outcome Measures:
Title
Evaluation of radiation proctitis by LENT SOMA Score
Description
Evaluation of radiation proctitis with clinical symptoms using LENT SOMA Score.The minimum value is 0, and maximum is 4. Higher scores mean a worse outcome.
Time Frame
two months
Title
Evaluation of radiation proctitis by rectal chemoradiotherapy toxicity scale
Description
Evaluation of radiation proctitis with clinical symptoms using rectal chemoradiotherapy toxicity scale.The minimum value is 0, and maximum is 5. Higher scores mean a worse outcome.
Time Frame
two months
Title
Evaluation of radiation proctitis by fiberoptic proctoscopy
Description
Evaluation of radiation proctitis with fiberoptic proctoscopy using Vienna Rectoscopy Score. The minimum value is 0, and maximum is 3/4. Higher scores mean a worse outcome.
Time Frame
two months
Title
changes in gut microbiota by 16S rRNA sequencing technology
Description
To detect changes in gut microbiota with 16S rRNA sequencing,including changes in species diversity and abundance of gut microbiota.
Time Frame
two months
Title
Changes in serum inflammatory factors
Description
Assess changes in serum inflammatory factors , including IL-2、IL-6,CRP、TNFa, etc.
Time Frame
two months
Title
QOL C29
Description
Assess patients' subjective feeling of life using EORTC QOL C29.The minimum value is 1, and maximum is 4. Higher scores mean a worse outcome.
Time Frame
two months
Title
QOL C30
Description
Assess patients' subjective feeling of life using EORTC QOL C30.The minimum value is 1, and maximum is 4. Higher scores mean a worse outcome.
Time Frame
two months
Title
tumor imaging assessment
Description
Evaluation of tumor changes with imaging methods,including treatment response with complete response, partial response or stable disease according to RECIST 1.1 after 1 month after concurrent chemoradiotherapy.
Time Frame
two months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: locally advanced rectal adenocarcinoma diagnosed by histopathology; clinical stage T3/4 or N+(AJCC,8th), no metastasis; and planned to receive preoperative neoadjuvant concurrent chemoradiotherapy. without other malignant tumors; Those without serious heart, liver, kidney and other diseases; ECOG score: 0-1. Exclusion Criteria: Complicated with ulcerative colitis or Crohn's disease; Complicated with severe organ insufficiency, severe diabetes, and heart disease; Pregnant and lactating women; Abnormal bowel movements with systemic and metabolic diseases; The patient has a history of using systemic antibiotics and intestinal active bacteria in the past 1 month.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
xin wang, PhD/MD
Phone
+86 28 85423609
Email
wangxin213@sina.com
First Name & Middle Initial & Last Name or Official Title & Degree
min ren, PhD/MD
Phone
+86 28 85423609
Email
renmin0502@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
xin wang
Organizational Affiliation
China, SiChuan West China Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
West China Hospital
City
Chengdu
State/Province
Sichuan
ZIP/Postal Code
610041
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xin Wang, PhD/MD
Phone
+86 28 85423609
Email
wangxin213@sina.com
Facility Name
Xin Wang
City
Chengdu
State/Province
Sichuan
ZIP/Postal Code
610041
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
xin wang, PhD/MD
Phone
+86 28 85423609
Email
wangxin213@sina.com

12. IPD Sharing Statement

Learn more about this trial

The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis

We'll reach out to this number within 24 hrs